At the center of this discovery stands a molecule called NAD, or nicotinamide adenine dinucleotide. The results have been published in Nature Metabolism. Professor Mathias Ziegler from the ...

CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the NAD pathway ...

CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the NAD pathway ...